α-Galactosidase A deficiency. Fabry disease

By R. Desnick. 2001

821 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/f63bf98197e42e35599ca3264e8ca40c83c70082

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Germain
2. R. Brady
3. J. Barranger
4. A. Collins
5. M. Goldman
6. G. Grabowski
7. S. Packman
8. W. Wilcox

Citations in the corpus

• Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy (2003, background): “The disease is panethnic, and estimates of incidence range from about 1 in 40 000 to 60 000 males (5, 9).”
• Enzyme replacement therapy in Fabry disease: a randomized controlled trial. (2001, background): “The development of antibodies is not surprising given the fact that the majority of patients with Fabry disease do not synthesize a fulllength enzyme.(26) Even these low-titer antibodies decreased over time, indicating the induction of tolerance.”